Li Chengxian, Wu Fucang, Yuan Weiling, Ding Qi, Wang Min, Zhang QingQing, Zhang Ju, Xing Jingyu, Wang Shang
Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
Beijing University of Chinese Medicine Dongfang College, Beijing 065001, China.
Evid Based Complement Alternat Med. 2019 Sep 19;2019:9458676. doi: 10.1155/2019/9458676. eCollection 2019.
Chronic simple pharyngitis (CSP) is a common clinical chronic respiratory inflammation with persistent and intransigent symptoms. We analyzed the clinical data to find the evidence that herbal tea, a traditional Chinese medicine treatment in China, could improve the symptoms of CSP patients in a simple way.
We systematically reviewed the clinical data of randomized controlled treatments from April 2019 and evaluated the results using the improved Jadad scale and the Cochrane bias risk assessment tool. RevMan 5.3 software was used for chart analysis. In addition, we used Excel to conduct frequency statistics on Chinese herbs from included articles and analyze its medication rules.
Among the collection of 161 articles, 6 RCTs published in Chinese journals were included in this review. The methodological quality of the treatments was low, and most of them only provide diagnostic criteria. Inclusion and exclusion criteria were not specified, and none of the 6 RCTs used the blind method on the result evaluator. Furthermore, only one RCT evaluated the baseline level variance. For these reasons, we did not make a network meta-analysis.
The traditional Chinese herbs involved in herbal tea did have ingredients to alleviate CSP symptoms. However, our research showed that the current research could not draw any credible conclusions on the curative effect of herbal tea, which indicated that the overall level of TCM clinical research needs to be improved to evaluate the efficacy of herbal tea.
慢性单纯性咽炎(CSP)是一种常见的临床慢性呼吸道炎症,症状持续且顽固。我们分析临床数据,以寻找证据证明在中国作为一种中医疗法的凉茶能够以简单的方式改善CSP患者的症状。
我们系统回顾了2019年4月以来随机对照治疗的临床数据,并使用改良的 Jadad 量表和Cochrane偏倚风险评估工具对结果进行评估。使用RevMan 5.3软件进行图表分析。此外,我们使用Excel对纳入文章中的中药进行频次统计并分析其用药规律。
在收集的161篇文章中,本综述纳入了6篇发表在中国期刊上的随机对照试验。这些治疗的方法学质量较低,大多数仅提供诊断标准。未明确纳入和排除标准,6项随机对照试验中没有一项对结果评估者采用盲法。此外,只有一项随机对照试验评估了基线水平差异。由于这些原因,我们未进行网状Meta分析。
凉茶中所涉及的传统中药确实含有缓解CSP症状的成分。然而,我们的研究表明,目前的研究无法就凉茶的疗效得出任何可信的结论,这表明中医临床研究的整体水平需要提高以评估凉茶的疗效。